Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Neugebauer, E; Rixen, D; Raum, M; Schäfer, U.
Thirty years of anti-mediator treatment in sepsis and septic shock--what have we learned?
Langenbecks Arch Surg. 1998; 383(1):26-34 Doi: 10.1007/s004230050088
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Schäfer Ute
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Sepsis, the systemic response (specific and non-specific) of the body to an infection, is an increasing clinical problem. During the last 30 years, nearly 50 clinical trials involving more than 10,000 patients have failed to demonstrate improvement of patients' outcome with different "anti-mediator" strategies. The wrong conceptional approaches to interact with the complex mediator network and flaws in study design and conduct are the main reasons for this disappointing situation. We learned, however, that the systemic host response is more than persistent uncontrolled inflammation; it is also a stimulation of the counter regulatory network. Although it is important to analyse the complex picture, we have now reached a point where more sophisticated strategies for describing complexity and novel attempts for synthesis are needed. Along this line, improved study designs (decrease of "signal-to-noise ratio") are mandatory. In addition, secondary preventive strategies are emphasised.
Find related publications in this database (using NLM MeSH Indexing)
Clinical Trials as Topic -
Humans -
Inflammation Mediators - antagonists and inhibitors
Research Design - antagonists and inhibitors
Shock, Septic - drug therapy
Systemic Inflammatory Response Syndrome - drug therapy
Treatment Outcome - drug therapy

Find related publications in this database (Keywords)
sepsis
mediators
antimediators
modulation
study design
complexity
© Med Uni GrazImprint